Background and Purpose-Anticoagulation reduces the risk of stroke in nonvalvular atrial fibrillation yet remains underused. We explored barriers to the use of anticoagulants among Australian family physicians. Methods-The authors conducted a representative, national survey. Results-Of the 596 (64.4%) eligible family physicians who participated, 15.8% reported having a patient with nonvalvular atrial fibrillation experience an intracranial hemorrhage with anticoagulation and 45.8% had a patient with known nonvalvular atrial fibrillation experience a stroke without anticoagulation. When presented with a patient at "very high risk" of stroke, only 45.6% of family physicians selected warfarin in the presence of a minor falls risk and 17.1% would anticoagulate if the patient had a treated peptic ulcer. Family physicians with less decisional conflict and longer-standing practices were more likely to endorse anticoagulation. 
Anticipated Responsibility
Approximately one fifth (17.6%) anticipated feeling most responsible for an intracranial hemorrhage on anticoagulation, whereas 31.5% anticipated feeling most responsible for an ischemic stroke in a patient without anticoagulation.
FPs who anticipated feeling most responsible for an intracranial hemorrhage were more likely to have previously experienced this outcome compared with FPs who anticipated feeling most responsible for a stroke (21.9% versus 11.2%; 2 [2] ϭ6.11; Pϭ0.047). The experience of a stroke was not correlated with FPs' anticipated responsibility for adverse outcomes ( 2 [2] ϭ3.42; Pϭ0.18).
Self-Reported Management of Nonvalvular Atrial Fibrillation
Although most FPs selected warfarin for the 65 year old at "high" risk of stroke (case 2), fewer selected warfarin for the 75 year old at "moderate to high" risk or at "very high" risk of stroke (cases 3 and 4) (PsϽ0.001) ( Table 3) .
Effect of Perceived Bleeding Risk
Although 71.0% of respondents selected warfarin for the 75-year-old patient at "very high" risk of stroke (case 4), 45.6% selected warfarin when this patient was described as having a minor falls risk (case 5). Only 17.1% and 28.9%, respectively, would do so if case 4 had a recent gastrointestinal bleed now on antiulcer treatment (case 6) or frequent nosebleeds (case 7; Table 3 ).
Twenty-nine percent (29.2) switched their preference for warfarin when case 4 was described as having a "minor falls risk" (case 5). These FPs had been in family practice for fewer years (meanϭ17.2 years) than FPs who maintained their preference (meanϭ21.1 years) or who had not initially selected warfarin (meanϭ18.5 years; Pϭ0.001).
Over half (57.7%) switched their preference from warfarin if case 4 had a gastrointestinal bleed caused by a peptic ulcer (now treated; case 6). FPs who maintained their preference for warfarin had been practicing for longer (Pϭ0.026) and had less decisional conflict than other FPs (Pϭ0.008).
Just under half (46.6%) switched their preference from warfarin when case 4 was described as having frequent nose bleeds (case 7).
Only 8.1% of FPs maintained a preference for warfarin when case 4 had a history of a hypertensive intracranial hemorrhage (case 8). Compared with other FPs, these FPs were more likely to have had a patient experience an intracranial hemorrhage on anticoagulation (Pϭ0.045), to feel most responsible for a stroke (Pϭ0.054), and to be members of Australia's peak organization for family practitioners (Pϭ0.013).
Discussion
Experience of bleeding events and fear of bleeding appear to influence prescribing. Furthermore, the experience of an intracranial hemorrhage in a patient with NVAF with anticoagulation appeared to condition FPs to feeling responsible for this outcome. However, the more common experience of a stroke did not affect their sense of responsibility. Clinicians may have more "chagrin" over harm arising from so-called acts of commission because they are inculcated to first "do no harm." 9 They may therefore abandon potentially harmful therapies, even if the benefits outweigh the risks. 9 Our findings are consistent with a recent study showing that clinicians are less likely to prescribe anticoagulants for NVAF if any one of their patients experiences a serious bleeding event yet are no more likely to prescribe warfarin if a patient with NVAF experiences a stroke. 10 For a patient at "very high risk" of stroke, the majority would substitute warfarin with another treatment if the patient has nose bleeds, treated peptic ulcers, and a minor falls risk, although these bleeding risks are preventable and outweighed by the benefits of anticoagulation. 7, 11 FPs with longerstanding practices were more likely to maintain a preference for warfarin, indicating that experience desensitizes FPs to fears of anticoagulation. Reduced decisional conflict may also increase anticoagulant prescribing. Anticoagulation for patients with a history of an intracranial hemorrhage remains controversial 12 and was not endorsed by the majority of FPs. However, the minority maintaining a preference for 
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warfarin who did so felt more responsible for a stroke and did so despite having patients experience an intracranial hemorrhage.
Our results may only generalize to FPs and the usual caveats about self-reported data apply. Our results commend the implementation of interventions that will reduce fears about bleeding, promote a rational appraisal of the risk and benefits of anticoagulation, and resolve decisional conflict. In the article entitled "Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation: A Representative Survey of Australian Family Physicians" by Gattellari et al, 1 the authors have several data changes in Table 2 to report. Please see below for the correct data (shown in bold). The authors regret this error.
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The corrected version is now available online at http://stroke.ahajournals.org. 
